Riskpilot← Back to searchSign inGet full accessPharma-Hus Aktiebolag
ABActiveOrg 5562474493Gunnebogatan 28Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19845-9 employees
Revenue 2024
SEK 26,6M
-12% vs 2023
EBITDA margin
5.7%
+38% vs 2023
Equity ratio
19.6%
Financial strength
Net profit 2024
SEK 1,2M
+48% vs 2023
| Revenue | SEK 26,6M | -12% |
| EBITDA | SEK 1,5M | +38% |
| Net profit | SEK 1,2M | +48% |
| Total assets | SEK 6,6M | -40% |
| Equity | SEK 1,3M | +41% |
| Employees | — | — |
Legal name
Pharma-Hus Aktiebolag
Org number
5562474493
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6 september 1984
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Dam, Jörgen Wallin, Eli Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva försäljning av hälsokostprodukter samt läkemedel ävensom idka annan därmed förenlig verksamhet.
Address
Gunnebogatan 28
Phone
+4687609167
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 25 426 | 27 403 | 28 599 | 30 205 | 26 641 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 182 | 421 | 409 | 1 100 | 1 523 |
| Depreciation & amort. | −80 | −240 | −130 | −151 | −144 |
| EBIT | 102 | 181 | 279 | 949 | 1 379 |
| Net financials | 11 | −2 | −2 | 15 | 61 |
| Profit before tax | 425 | 465 | 500 | 1 023 | 1 502 |
| Tax | −98 | −104 | −110 | −225 | −323 |
| Net profit | 327 | 361 | 390 | 798 | 1 179 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 106 | 5 599 | 9 835 | 10 963 | 6 603 |
| Equity | 457 | 518 | 508 | 916 | 1 295 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 374 | 3 091 | 7 560 | 8 339 | 3 661 |
| Total debt | 2 374 | 3 091 | 7 560 | 8 339 | 3 661 |
EBITDA margin
5.7%
This company
15.8%
Market median
-64% vs market
20202024
Equity ratio
19.6%
This company
38.2%
Market median
-49% vs market
20202024
Return on equity
91.0%
This company
18.4%
Market median
+395% vs market
20202024
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
20202024
Asset turnover
4.03×
This company
1.12×
Market median
+260% vs market
20202024
Debt / equity
4.10×
This company
0.62×
Market median
-561% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
EJ Authorized Recipient of Service | Authorized Recipient of Service | 2024 |
AM Audit | Audit | 2022 |
MM Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (3) | ||
EL Audit | Audit | 2021 – 2022 |
MS Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2021 |
JH Authorized Recipient of Service | Authorized Recipient of Service | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHARMA NORD APS
Pharma-Hus Aktiebolag (this company)Board members of Pharma-Hus Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emma Johanna Astvik | Authorized Recipient of Service | 0 companies |
| Eric Lindahl | Audit | 0 companies |
| Anna Maria Andersson | Audit | 0 companies |
| Michael Maul Svarrer | Chief Executive Officer | 0 companies |
| Moesgaard Sven | Authorized Recipient of Service | 0 companies |
| Jessica Hanna-Lena Glimmra | Authorized Recipient of Service | 0 companies |
| Eli Wallin | Deputy Board Member | 0 companies |
| Jörgen Dam | Board of Directors | 0 companies |